Has Kyle Anderson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,098,270 in general payments to Kyle Anderson, MD across 253 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Anderson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Anderson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Anderson, MD

Orthopaedic Surgery · Bingham Farms, MINPI 1952383176

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,836,525 of the $3,098,270 with a category attached, or 91.6%. Arthrex accounts for 99.8% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $903,534, 9.6 times the $94,079 reported in 2019. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,098,270in general payments, 2019–2025

Across 253 payments — averaging $12,246 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$3.1M
Pinnacle, Inc$4K
Stryker$84
Pacira Therapeutics, Inc.$62
Ferring Pharmaceuticals Inc.$48
Boston Scientific$47
plus $224 from 8 others

$46,463in research payments, 2019–2025

Across 27 payments — averaging $1720.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$34K
Zimmer Biomet$12K

What the payments were for

Royalty or licence$2,836,52592%
Consulting fees$167,3595%
Speaking & faculty fees$71,3462%
Travel & lodging$15,3340%
Food & beverage$4,1060%
Education$3,6000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	209	$3,093,348
Pinnacle, Inc	22	$4,457
Stryker	2	$84
Pacira Therapeutics, Inc.	2	$62
Ferring Pharmaceuticals Inc.	3	$48
Boston Scientific	3	$47
Bioventus LLC	1	$45
Kowa Pharmaceuticals America, Inc.	3	$42
Pacira Pharmaceuticals Incorporated	2	$33
Amgen	2	$28
ERMI LLC	1	$25
Biotissue Holdings Inc.	1	$24
Anika Therapeutics, Inc.	1	$19
Musculoskeletal Transplant Foundation Inc.	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$12,286,999
SHOULDER IMPLANTS FIBERTAK KNOTLESS$172,903
SHOULDER INSTRUMENTS ELBOWS UCL$172,903
KNEE & HIP IMPLANTS HIP FIBERTAK$167,823
SHOULDER IMPLANTS ROTATOR CUFF FIBERTAK$135,336
ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$113,867
ARTHROPLASTY INSTRUMENTS ANATOMIC TOTAL SHOULDER UNIVERS$59,036

How this compares

$3,098,270 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan →

Medicare billing

Part B allowed, 2024

$169,053

Medicare patients

393

Services billed

3,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	43	$281
Celecoxib	15	$155
Meloxicam	43	$88
Naproxen	18	$52
Tramadol Hcl	20	$45
Amoxicillin	36	$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bingham Farms

Mark KaradshehBingham Farms$108K
Asheesh BediAnn Arbor$9.4M
Jerome WiaterBeverly Hills$3.9M
Mark PintoChelsea$3.2M
Stephen BartolDetroit$2.6M
Jad KhalilSouthfield$1.9M
Jeffrey FischgrundSouthfield$1.8M
John BlahaAnn Arbor$1.5M
David MarkelSouthfield$1.5M
Christopher ChuinardTraverse City$1.4M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →